Skip to Content
MilliporeSigma
All Photos(1)

Documents

EHU059671

Sigma-Aldrich

MISSION® esiRNA

targeting human ELF4

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GTTGGACGACGTTCACAATGGCATCATAACAGACGGGACCTTGTGCATGACGCAGGATCAGATCCTGGAAGGCAGTTTTTTGCTGACAGATGACAATGAGGCCACCTCGCACACCATGTCAACCGCGGAAGTCTTACTCAATATGGAGTCTCCCAGCGATATCCTGGATGAGAAGCAGATCTTCAGTACCTCCGAAATGCTTCCAGACTCGGACCCTGCACCAGCTGTCACTCTGCCCAACTACCTGTTTCCTGCCTCTGAGCCCGATGCCCTGAACAGGGCGGGTGACACTAGTGACCAGGAGGGGCATTCTCTGGAGGAGAAGGCCTCCAGAGAGGAAAGTGCCAAGAAGACTGGGAAATCAAAGAAGAGAATCCGGAAGACCAAGGGCAACCGAAGTACCTCACCTGTCACTGACCC

Ensembl | human accession no.

ENSG00000102034

NCBI accession no.

NM_001421

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... ELF4(2000) , ELF4(2000)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Jeanne L Theis et al.
eLife, 9 (2020-10-03)
Congenital heart diseases (CHDs), including hypoplastic left heart syndrome (HLHS), are genetically complex and poorly understood. Here, a multidisciplinary platform was established to functionally evaluate novel CHD gene candidates, based on whole-genome and iPSC RNA sequencing of a HLHS family-trio.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service